PRESS RELEASE
3 August 2022

Holland & Knight Health Dose: August 2, 2022

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • Reconciliation Back on the Menu with Possible Senate Action by Week's End
  • Ways and Means Advances Prior Authorization Bill
  • Senate Appropriators Release Fiscal Year 2023 Spending Bills
  • Telehealth Bill Passes the House
  • CMS Releases Final 2023 Medicare Inpatient and Nursing Home Rules
  • 3 More States Extend Medicaid Coverage for New Mothers
  • CMS Announces Projected 2023 Medicare Part D Premiums
  • CMS Holds Webinar on Unwinding the COVID-19 PHE
  • MACPAC Holds Meeting and Discussion on FMAP

Read the full Health Dose »

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More